← Library

Tesofensine

Peptide

An oral peptide for brain-focused appetite control and weight-loss support

Tesofensine is an oral peptide that boosts brain levels of serotonin, norepinephrine, and dopamine to help reduce appetite and cravings. Unlike GLP-1 medications that target gut-brain hormones, this approach directly influences the neurotransmitter systems that shape hunger and fullness. It provides a unique option for structured weight management, offering appetite control alongside steady energy and mood support.

Suggested use: Once-daily oral capsule. Doses are slowly microdosed and titrated based on individual response and tolerance under physician supervision.

May help with

Weight lossAppetite and cravingsAlternative to GLP-1 medicationsStalled weight lossStructured weight managementEnergy and mood support

Key ingredients

  • Tesofensine

Product handout

TESOFENSINE

Appetite & Weight-Loss Support

WHAT IT IS:

An orally dosed peptide that boosts brain levels of serotonin, norepinephrine, and dopamine to reduce appetite and support weight loss.

WHY YOU NEED IT:

A Distinct, Brain-Focused Approach to Appetite

Important for patients who have struggled with appetite and cravings despite diet and exercise

Supports patients seeking an alternative mechanism to GLP-1 medications

Good for patients who prefer a once-daily oral capsule over weekly injections

Great for patients who want appetite control alongside steady energy and mood support

Supports patients pursuing physician-guided, structured weight management

Important for patients whose weight loss has stopped and need a different approach

HOW IT HELPS:

Appetite is governed by powerful brain chemistry. Tesofensine is designed to work directly on the neurotransmitter systems that shape hunger, fullness, and motivation.

Raising Three Key Neurotransmitters

Tesofensine boosts the levels of key brain neurotransmitters by blocking the reuptake of serotonin, norepinephrine, and dopamine. By increasing the availability of these signals, Tesofensine reduces appetite and food intake — a mechanism fundamentally different from GLP-1 drugs, which act on gut-brain satiety hormones.

Clinical Signal in Weight Loss

Originally investigated for neurological conditions, Tesofensine drew attention when trials showed significant weight loss. In a study published in the respected science journal, The Lancet, patients lost a meaningful percentage of body weight over 24 weeks — results that exceeded several other weight-loss agents.

What to Expect

Because it acts on central neurotransmitters, Tesofensine is typically started at a low dose and microdosed slowly to the desired clinical effectiveness. The most common effects are dry mouth and insomnia, with possible increases in heart rate or blood pressure, mild nausea, or restlessness in sensitive individuals. Blood pressure and heart rate monitoring are part of responsible use.

Who Should Not Use Tesofensine

Tesofensine is not appropriate for patients with uncontrolled high blood pressure, significant cardiovascular disease, certain psychiatric conditions, those taking interacting medications (such as MAO inhibitors or other serotonergic drugs), women who are pregnant or breastfeeding, or patients with a known hypersensitivity.

DOSAGE:

Adjustment: Doses are slowly microdosed based on response and tolerance; tolerance to appetite effects may develop over several weeks, and cycling may be necessary in some patients.

Titration: Dosing must be individualized and supervised by a physician, with blood pressure and heart-rate monitoring.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.